Pralatrexate

Product NDC
43598-342
11-digit product format
435980342
Labeler code
43598
Product ID
43598-342_b885a7b3-a241-638d-8f27-d162c562469a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pralatrexate
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Dr.Reddy's Laboratories Inc.,
Application
ANDA206183
Marketing category
ANDA
Marketing start
2026-03-04
Substance
PRALATREXATE
Active strength
20 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206183-001PRALATREXATEPRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10
A206183-002PRALATREXATEPRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A206183-001AP
A206183-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A206183-001PRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206183-002PRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206183-001PRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206183-002PRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08A206183-001PRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206183-002PRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-106a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206183-001PRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206183-002PRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10fd3edfee7708…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206183-001PRALATREXATE20MG/ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206183-002PRALATREXATE40MG/2ML (20MG/ML)SOLUTION / INTRAVENOUSAP2025-03-10a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A206183-001AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206183-002AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206183-001AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206183-002AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206183-001AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206183-002AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206183-001AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206183-002AP1fd3edfee7708…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206183-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206183-002AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Pralatrexate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PRALATREXATE20 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
A8Q8I19Q20Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1796419Internal RxNorm lookup
1796424Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
cc3df863-c51c-49c5-283a-d6808fb49258Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9b7d5d51-7400-92a9-21bd-e6b4843a9c2fProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43598-342-11Pralatrexate1 mL in 1 VIAL, SINGLE-DOSEINJECTION16
43598-342-11Pralatrexate1 in 1 CARTONINJECTION16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43598-342-11ML - Milliliter43598-3428fc63d72-acce-4b56-886f-c340736e855112026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PralatrexatePRALATREXATEDr.Reddy's Laboratories Inc.,cc3df863-c51c-49c5-283a-d6808fb492582025-08-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206183
application number: ANDA206183
ndc (product): 43598-342

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1796419PRALAtrexate 20 MG in 1 ML InjectionPSNcc3df863-c51c-49c5-283a-d6808fb492586
1796424PRALAtrexate 40 MG in 2 ML InjectionPSNcc3df863-c51c-49c5-283a-d6808fb492586
17964191 ML pralatrexate 20 MG/ML InjectionSCDcc3df863-c51c-49c5-283a-d6808fb492586
17964242 ML pralatrexate 20 MG/ML InjectionSCDcc3df863-c51c-49c5-283a-d6808fb492586
1796419pralatrexate 20 MG per 1 ML InjectionSYcc3df863-c51c-49c5-283a-d6808fb492586
1796424pralatrexate 40 MG per 2 ML InjectionSYcc3df863-c51c-49c5-283a-d6808fb492586

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
43598-342-11435980342111 VIAL, SINGLE-DOSE in 1 CARTON (43598-342-11) / 1 mL in 1 VIAL, SINGLE-DOSE2026-03-04NoNoCurrent